Učitavanje...
Comparing HMG‐CoA reductase inhibitors
The statins have proved to be some of the most potent therapies for reducing elevated low‐density lipoprotein (LDL) cholesterol and lessening the risk of coronary heart disease (CHD) and related events. Nonetheless, there are still questions about the clinical relevance of individual drug characteri...
Spremljeno u:
| Izdano u: | Clin Cardiol |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley Periodicals, Inc.
2007
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6653890/ https://ncbi.nlm.nih.gov/pubmed/12539818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960261306 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|